Alex Niu

MD
Medical Oncology and Hematology

Cancers Treated:

Hodgkin Lymphoma Lymphoma

Specializing In:

B-cell lymphoma T-cell lymphoma CLL/SLL

Research Interests:

Relapsed/Refractory diffuse large B-cell lymphoma Relapsed/Refractory classical Hodgkin Lymphoma Developing Cellular therapy with both Chimeric antigen receptor (CAR) T cell therapy and Bispecific T-cell engagers (BiTE)

About Alex Niu

Biography:

I am excited to join the lymphoma team here at Roswell Park Comprehensive Cancer Center. I attended medical school at Oregon Health and Science University in Portland, Oregon, after which I completed my internal medicine residency at the University of Cincinnati in Cincinnati, Ohio. This was followed by hematology-oncology fellowship at Tulane in New Orleans, Louisiana.

As the world of lymphoma has drastically changed recently, I decided to pursue an additional lymphoma fellowship at Mayo Clinic in Rochester, Minnesota before joining the team here at Roswell Park.

Buffalo is known as the city of good neighbors and I'm excited and honored to become a member of it.

Positions

Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Department of Medicine

Background

Education and Training:

  • 2012-2016 - MD - Oregon Health and Science University, Portland, OR

Residency:

  • 2016-2019 - Internal Medicine, University of Cincinnati, Cincinnati, OH

Fellowship:

  • 2022-2023 - Lymphoma fellowship, Mayo Clinic, Rochester, MN
  • 2019-2022 - Hematology-Oncology, Tulane School of Medicine, New Orleans, LA

Board Certification:

  • Internal Medicine - American Board of Internal Medicine
  • Medical Oncology - American Board of Medical Specialties
  • Hematology - American Board of Medical Specialties

Honors & Awards:

  • 2021 - SAFMR/SSCI Trainee Research Award for oral presentation of abstract: High False Negative Rate and High Mortality: COVID-19 Infection in Patients with Hematological Malignancies.
  • 2020 - ASH Abstract Achievement Award for oral presentation of abstract: COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality.
  • 2014 - Gold Humanism Honor Society

Publications

  • Niu A, McDougal A, Ning B, et al. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-0972-8. PMID: 32541689
  • Niu A, Ning B, Socola F, et al. High Mortality with High False Negative Rate: COVID-19 Infection in Patients with Hematologic Malignancies. Leukemia Research (2021). https://doi.org/10.1016/j.leukres.2021.106582
  • Pal P, Ibrahim M, Niu A, et al. Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients. Transfusion Medicine (2020).
  • Huang Z, Ning B, Yang H, Youngquist B, Niu A, et al. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV2 infection. The Journal of Clinical Investigation (2021). https://doi.org/10.1172/JCI146031.
  • Ning B, Huang Z, Youngquist B, Scott J, Niu A, et al. Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma. Nature Nanotechnology (2021). https://doi.org/10.1038/s41565-021-00939-8.